Atlas Trials

Pharmacokinetics of KBP-5074 in Patients With Moderate Hepatic Impairment

Clinical trial NCT04534699 · COMPLETED

Trial details

NCT number
NCT04534699
Sponsor
KBP Biosciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Moderate Hepatic ImpairmentHealthy
Start date
2020-08-27
Primary completion
2020-11-19
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.